Although the bone forming phenotype in prostate cancer, bioinformatics analysis of the mutations identified as pathogenic in BMP4 and exposed that both osteoblastic and osteolytic lesions are present in the same loci. The gene discussed is BMP4; the disease is prostate carcinoma.